blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3648747

EP3648747 - GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.07.2023
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  05.08.2022
FormerGrant of patent is intended
Status updated on  30.03.2022
FormerExamination is in progress
Status updated on  31.07.2020
FormerRequest for examination was made
Status updated on  10.04.2020
FormerThe international publication has been made
Status updated on  22.12.2018
Formerunknown
Status updated on  20.07.2018
Most recent event   Tooltip26.01.2024Lapse of the patent in a contracting state
New state(s): MC		published on 28.02.2024  [2024/09]
Applicant(s)For all designated states
Amneal Complex Products Research LLC
995 U.S. Highway 202/206
Bridgewater, NJ 08807 / US
[2021/35]
Former [2020/47]For all designated states
Kashiv Specialty Pharmaceuticals, LLC
995 U.S. Highway 202/206
Bridgewater NJ 08807 / US
Former [2020/20]For all designated states
Kashiv Biosciences, LLC
995 US 202/206
Bridgewater NJ 08807 / US
Inventor(s)01 / MEGHPARA, Kanji
60 Stockton Court
Morris Plains, NJ 07950 / US
02 / SANDHU, Harpreet Kaur
73 Manger Road
West Orange, NJ 07052 / US
03 / CHATTERJI, Ashish
7 Prescott Road
East Brunswick, NJ 08816 / US
04 / SHAH, Navnit H.
203 Beverly Hill Road
Clifton, NJ 07012 / US
05 / PHUAPRADIT, Wantanee
4 Effingham-Low Court
Montville, NJ 07045 / US
06 / DESAI, Dipen
202 Altaview Court
Whippany, NJ 07981 / US
07 / VAGHASHIYA, Jaydeep
1407 Van Wickle Dr.
Franklin Park, NJ 08823 / US
 [2020/39]
Former [2020/20]01 / MEGHPARA, Kanji
60 Stockton Court
Morris Plains, NJ 07950 / US
02 / SANDHU, Harpreet Kaur
73 Manger Road
West Orange, NJ 07052 / US
03 / CHATTERJI, Ashish
7 Prescott Road
East Brunswick, NJ 08816 / US
04 / SHAH, Navnit H.
203 Beverly Hill Road
Clifton, NJ 07012 / US
05 / PHUAPRADIT, Wantanee
4 Effingham-Low Court
Montville, NJ 07045 / US
06 / DESAI, Dipen
202 Altaview Court
Whippany, NJ 07981 / US
07 / VAGHASHIYA, Jaydeep
190 Roanoke Street
Woodbridge, NJ 07095 / US
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2020/20]
Application number, filing date18738169.418.06.2018
[2020/20]
WO2018US38118
Priority number, dateUS201762520796P16.06.2017         Original published format: US 201762520796 P
[2020/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018232413
Date:20.12.2018
Language:EN
[2018/51]
Type: A1 Application with search report 
No.:EP3648747
Date:13.05.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 20.12.2018 takes the place of the publication of the European patent application.
[2020/20]
Type: B1 Patent specification 
No.:EP3648747
Date:07.09.2022
Language:EN
[2022/36]
Search report(s)International search report - published on:EP20.12.2018
ClassificationIPC:A61K9/22, A61K31/403, A61K31/421, A61K31/55, A61K9/28, A61K9/24
[2020/20]
CPC:
A61K9/0065 (EP,US); A61K31/195 (US); A61K31/198 (EP,US);
A61K31/403 (US); A61K31/404 (EP,US); A61K31/4166 (US);
A61K31/421 (EP,US); A61K31/4412 (US); A61K31/4425 (EP,US);
A61K47/32 (US); A61K47/34 (US); A61K47/38 (US);
A61K9/0007 (US); A61K9/2018 (EP); A61K9/2054 (EP);
A61K9/2059 (EP); A61K9/284 (US); A61K9/2846 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/20]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:GASTRORETENTIVE DARREICHUNGSFORMEN FÜR VERZÖGERTE WIRKSTOFFFREISETZUNG[2020/20]
English:GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERY[2020/20]
French:FORMES POSOLOGIQUES À RÉTENTION GASTRIQUE DESTINÉES À UNE ADMINISTRATION DE MÉDICAMENT PROLONGÉE[2020/20]
Entry into regional phase26.02.2020National basic fee paid 
26.02.2020Designation fee(s) paid 
26.02.2020Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2020/20]
06.02.2020Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2020/20]
26.02.2020Amendment by applicant (claims and/or description)
26.02.2020Examination requested  [2020/20]
26.02.2020Date on which the examining division has become responsible
03.08.2020Despatch of a communication from the examining division (Time limit: M04)
01.10.2020Reply to a communication from the examining division
19.01.2021Despatch of a communication from the examining division (Time limit: M04)
25.02.2021Reply to a communication from the examining division
07.04.2021Despatch of a communication from the examining division (Time limit: M02)
26.05.2021Reply to a communication from the examining division
20.07.2021Despatch of a communication from the examining division (Time limit: M02)
15.09.2021Reply to a communication from the examining division
25.11.2021Despatch of a communication from the examining division (Time limit: M04)
05.01.2022Reply to a communication from the examining division
31.03.2022Communication of intention to grant the patent
27.07.2022Fee for grant paid
27.07.2022Fee for publishing/printing paid
27.07.2022Receipt of the translation of the claim(s)
Opposition(s)08.06.2023No opposition filed within time limit [2023/33]
Request for further processing for:26.02.2020Request for further processing filed
26.02.2020Full payment received (date of receipt of payment)
Request granted
27.03.2020Decision despatched
The application is deemed to be withdrawn due to non-payment of the filing fee
26.02.2020Request for further processing filed
26.02.2020Full payment received (date of receipt of payment)
Request granted
27.03.2020Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
26.02.2020Request for further processing filed
26.02.2020Full payment received (date of receipt of payment)
Request granted
27.03.2020Decision despatched
26.02.2020Request for further processing filed
26.02.2020Full payment received (date of receipt of payment)
Request granted
27.03.2020Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
26.02.2020Request for further processing filed
26.02.2020Full payment received (date of receipt of payment)
Request granted
27.03.2020Decision despatched
Fees paidRenewal fee
14.10.2020Renewal fee patent year 03
14.06.2021Renewal fee patent year 04
27.06.2022Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.202003   M06   Fee paid on   14.10.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL07.09.2022
AT07.09.2022
CZ07.09.2022
EE07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
MC07.09.2022
PL07.09.2022
RO07.09.2022
RS07.09.2022
SI07.09.2022
SK07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
IS07.01.2023
PT09.01.2023
[2024/09]
Former [2023/37]AL07.09.2022
AT07.09.2022
CZ07.09.2022
EE07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
PL07.09.2022
RO07.09.2022
RS07.09.2022
SI07.09.2022
SK07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
IS07.01.2023
PT09.01.2023
Former [2023/29]AL07.09.2022
AT07.09.2022
CZ07.09.2022
EE07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
PL07.09.2022
RO07.09.2022
RS07.09.2022
SK07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
IS07.01.2023
PT09.01.2023
Former [2023/26]AT07.09.2022
CZ07.09.2022
EE07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
PL07.09.2022
RO07.09.2022
RS07.09.2022
SK07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
IS07.01.2023
PT09.01.2023
Former [2023/23]AT07.09.2022
CZ07.09.2022
EE07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
RO07.09.2022
RS07.09.2022
SK07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
PT09.01.2023
Former [2023/22]AT07.09.2022
CZ07.09.2022
FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
RO07.09.2022
RS07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
PT09.01.2023
Former [2023/20]FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
RS07.09.2022
SM07.09.2022
NO07.12.2022
GR08.12.2022
Former [2023/10]FI07.09.2022
HR07.09.2022
LT07.09.2022
LV07.09.2022
RS07.09.2022
NO07.12.2022
GR08.12.2022
Former [2023/09]FI07.09.2022
LT07.09.2022
LV07.09.2022
RS07.09.2022
NO07.12.2022
Former [2023/08]FI07.09.2022
LT07.09.2022
RS07.09.2022
NO07.12.2022
Cited inInternational search[A]WO2004066981  (SUN PHARMACEUTICAL IND LTD [IN], et al);
 [IAY]US2004180086  (RAMTOOLA ZEBUNNISSA [IE], et al);
 [A]WO2008068731  (BIOVAIL LAB INT SRL [BB], et al);
 [XYI]US2010112053  (MOMOSE DENICHI [JP], et al)
by applicantUS4101650
 US4777033
 US4844905
 WO0015198
 WO0110419
 WO0200213
 US2010305208
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.